Hence, high RvD scores are associated with improved outcomes and enhanced CD8+ T cell anti-tumor immunity, suggesting that stimulation of the RvD pathway may prime leukocyte-dependent inhibition of HNSC cancer progression. This evidence concerns the gene CD8A and neoplasm.